The global Auditory Brainstem Implant market was valued at USD 57.7 Million in 2018 and is expected to reach USD 76.9 million by the year 2026, at a CAGR of 3.6%. An auditory brainstem implant (ABI) is operated on people suffering from profound sensorineural hearing loss. The auditory brainstem implants directly aids in the functioning of the hearing pathway of the brainstem without any interaction with the hearing nerve or inner ear which involves a complex neurosurgery to the brainstem. The major use of this procedure is for the adults diagnosed with neurofibromatosis type 2, a rare genetic disorder which causes development of tumors on the nerve. However it is being operated now on children as well as adults with other inner ear and nerve abnormalities. One of the initial hearing aid machines for brainstem implants were by Cochlear Ltd.’s, a leading company in electronic hearing machines industry, Nucleus 24 ABI for teenagers and adults which got FDA approved in the year 2000. In recent years few other machines have gained popularity due to their MRI compatible machines.
According to World Health Organization, approximately 466 million people across the globe have disabling hearing loss, out of which 34 million are children. It is projected that by 2050 around 900 million individuals will have disabling hearing loss. These dynamics are likely to affect the ABI market in the future. Other factors such as the rising geriatric population, increasing incidence of hearing loss by birth, and rising noise pollution issues around the globe are anticipated to drive the market. However the brainstem implants are associated with few risks during and after the implantations which will impede the growth of this industry.
Companies considered and profiled in this market study:
Cochlear Limited (Australia), Med-EL (Austria), Oticon Medical (Denmark), Nurotron’s Biotechnology Co. Ltd. (China), Sonova Holding AG (Switzerland) collectively constituting a competitive market.
Get a Free Sample now@ https://www.reportsanddata.com/sample-enquiry-form/2173
For the purpose of this report, Reports and Data has segmented the Auditory Brainstem Implant market on the basis of medical condition, components used, end users and region:
Medical Condition Outlook (Revenue in Million USD; 2016–2026)
- Major Cochlear Malformation
- Complete Cochlear Ossification
- Fracture of the Petrous Pyramid
- Axonal Neuropathy
- Auditory Nerve Tumours
- Complete Oliteration of both Auditory Nerves
Components Outlook (Revenue in Million USD; 2016–2026)
- Microphone
- Decoding Chip
- Electrodes
End User Outlook (Revenue in Million USD; 2016–2026)
- Adults
- Pediatric
Regional Outlook (Revenue in USD Million; 2016–2026)
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia)
Order now@ https://www.reportsanddata.com/checkout-form/2173
Further key findings from the report suggest:
- According to CDC, (Center for Disease Control and Prevention), over 30% of the total hearing loss complications after birth are caused by infections during pregnancy, environmental causes and certain complications after birth. Moreover according to the data, nearly 50-60% of the cases of hearing loss in children are due to the genetic defects which leads to further complications.
- Current cochlear implants are unable to regain hearing in patients with inner ear injury. It is required to have a direct electrical stimulation of the auditory brainstem, which can be achieved using an ABI. The success of neuroprosthetic ABIs has been limited, with patients often only recovering sound perception rather than full hearing.
- The clinical ABI machines are stiff and creates hindrance in hearing due to the brainstem’s curved shape. A research Institute of Switzerland called EPFL with clinicians from Harvard Medical School and Massachusetts Eye and Ear developed a new implant device of soft electronic interface made from a pliable platinum array. This device is elastic and comfortable to be fitted around the curvature of the brainstem.
- North America remains the key revenue generating geographical segment in Auditory Brainstem Implant market. The geographical segment accounted for USD 20.8 million in 2018. Availability of research funds from public as well as private sources, availability of state-of-art technologies, presence of key market players in the region, favorable reimbursements for implantation procedures, rising focus on precision devices, and rising awareness about effectiveness of implantation surgeries, are among the key factors driving the market growth for Auditory Brainstem Implant in this region
Request for customization@ https://www.reportsanddata.com/request-customization-form/2173
Thank you for reading this article. You can also get chapter-wise sections or region-wise report coverage for North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
